Episode Details
Back to Episodes
XBI vs FBT Biotech ETFs Compared | Business and Finance News
Description
Biotech investing gets spicy with two ETFs: XBI for broad, high-growth exposure and FBT for focused, stable returns. XBI’s 76% one-year gain outpaces FBT’s 48.8%, but comes with higher risk—beta 1.14 vs. FBT’s 0.66. XBI holds 155 companies (top holdings under 2%), while FBT’s 30 stocks dominate with over 4% each. FBT weathered downturns better, with a 29.9% max drawdown vs. XBI’s 54%. Choose XBI for explosive upside or FBT for steadier sailing—your risk tolerance decides the path.
Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN:
advertise@thednn.ai
This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.
View sources & latest updates:
https://sources.thednn.ai/a6435c5269f8bd36